A clinical trial can offer you the chance to try new treatments and possibly benefit from them. Learning a new therapy is better than the standard treatment can also help others.
Whether a new therapy or test becomes part of standard treatment for breast cancer depends largely on the results of clinical trials.
Some clinical trials compare a new treatment to the standard of care. So, not everyone in the trial gets the new treatment. However, even those who don’t get the new treatment will still get the standard treatment, just as they would if they didn’t join the trial.
Talk with your oncologist about clinical trials. But remember, like all aspects of cancer care, the decision to join a clinical trial is a very personal one.
Learn more about clinical trials, including how to enroll and the informed consent process.
Find a list of questions to ask your doctor about clinical trials.
Some people worry they will get a placebo instead of an effective treatment in a clinical trial. However, placebos aren’t used in metastatic breast cancer clinical trials. You will get either the new treatment or the standard treatment.
If your medical center does not offer clinical trials, you may want to get a referral to a cancer center that does.
BreastCancerTrials.org in collaboration with Susan G. Komen® offers a custom matching service to help you find a clinical trial for people with metastatic breast cancer.
What is Susan G. Komen® doing?
Susan G. Komen® is one of several organizations to support the Reagan-Udall Foundation and the Food and Drug Administration (FDA) in developing an Expanded Access Navigator website. This new, online tool serves as a clearinghouse of information and resources about Expanded Access (EA), allowing patients and their doctors to access information more easily that could impact treatment decisions. EA, also known as “compassionate use,” provides access to an investigational drug prior to regulatory approval by the FDA for patients who have exhausted their treatment options and are not eligible for, or able to participate in, a clinical trial. The EA Navigator explains what EA is, who may be eligible, how the request process works, and the regulatory and policy issues around EA.
Metastatic Breast Cancer
Research Fast Facts
Facts for Life: Metastatic Breast Cancer
Breast Cancer Clinical Trial Information Helpline
Metastatic Breast Cancer Progress
1-877 GO KOMEN(1-877-465-6636)